… This study provides an overview of the evidence-based role of remdesivir, favipiravir, and
lopinavir/ritonavir in the management of COVID-19. A thorough assessment of the benefit-risk …

… remdesivir, hydroxychloroquine, and lopinavir-ritonavir combinations. These compounds
have been frequently touted as top candidates to treat COVID-19, but recent clinical reports …

… This study compared the effects of lopinavir/ritonavir and remdesivir on COVID-19 patients
… three groups: lopinavir/ritonavir, remdesivir, and control. We assessed the efficacy of these …

… review the available evidence on the efficacy of LPV/r in COVID-… , a somewhat higher binding
efficiency, and a somewhat higher … that both remdesivir and LPV (but not ritonavir) inhibited …

… is administered, the effects of other pharmacologic therapies given concurrently, such as
steroids, as well as other experimental treatment options such as chloroquine and remdesivir. …

… Here we evaluated the efficacy of the Lopinavir/Ritonavir (… We evaluated the medication
efficacy by comparing the time of … /r and Novaferon may have better efficacy against COVID-19. …

… The study aimed to investigate whether lopinavir/ritonavir (LPV/r) in combination with other
… Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and inter…

… -19 include remdesivir, hydroxychloroquine with or without azithromycin, and lopinavir/ritonavir.
None of these drugs have high certainty evidence evaluating their effectiveness for key …

… a combination of lopinavir, ritonavir and interferon beta (LPV/RTV-IFNb) is currently
being evaluated in humans in the Kingdom of Saudi Arabia. Here, we show that remdesivir (RDV) …

… An in silico test of the COVID-19 RdRp built model suggested the effectiveness of remdesivir
as a potent drug [22]. SARS-CoV and SARS-CoV-2 both belong to the betacoronaviruses of …